Botanical Solution, Inc. Amplifies Vaccine Adjuvant Production with a Fresh $7 Million Investment
Botanical Solution Inc. (BSI), a global trailblazer in the production of sustainable Advanced Botanical Materials, announces the addition…
Immunis, Inc. Recognized as a Finalist in the Octane High Tech Awards for Best Emerging Technology Company
Immunis, Inc., a pioneering entity in the biotechnology landscape, has achieved a significant milestone by being named a…
CEL-SCI Multikine Phase 3 Data Highlighted at ESMO 2022
CEL-SCI recently presented its Phase 3 data at ESMO 2022, which revealed that Neoadjuvant Multikine achieved groundbreaking tumor…
SyneuRx CEO Dr. Emil Tsai Exclusive Interview with Insights & Projections
Our BioTech Health X CEO Series continues with an exclusive interview with Dr. Emil Tsai of SyneuRx. Today…
Mayo Clinic, Hibiscus BioVentures, and Innoforce Announce Mayflower Cell and Gene Therapy Accelerator
Mayo Clinic, Hibiscus BioVentures (Hibiscus), and Innoforce have announced the formation of Mayflower BioVentures, a cell and gene…
Krystal Biotech Announces FDA IND Acceptance for KB407 Cystic Fibrosis Clinical Trial
Leader in redosable gene therapy Krystal Biotech, Inc. (NASDAQ: KRYS) announced today the United States Food and Drug…
ImmunityBio Announces FDA Acceptance of BLA for N-803 Anktiva Bladder Cancer Drug
In breaking news, clinical-stage biotechnology company ImmunityBio, Inc. (NASDAQ: IBRX) has announced acceptance by the FDA review of…
Brickell Biotech Regains Nasdaq Compliance Meeting Minimum Bid Price Requirement
Clinical-stage pharmaceutical company Brickell Biotech, Inc. (Nasdaq: BBI) announced that the company has received formal notice from The…
Merck Announces Failure in Keytruda Head and Neck Cancer Phase 3 Clinical Trial
Today Merck & Co. (NYSE: MRK) announced that Keytruda has failed the Phase 3 clinical trial KEYNOTE-412 evaluating…
What is Biotechnology: Types, Examples and Applications
Understanding biotechnology Biotech involves studying organism functions at the molecular level and is often combined with many different…
Ocugen Announces FDA Clinical Hold Removal for Phase 2/3 COVAXIN (BBV152) Clinical Trial
Biotechnology company Ocugen, Inc. (NASDAQ: OCGN) announced today that the U.S. Food and Drug Administration (FDA) has removed…
BenchSci Expands Advisory Board with New Pharma R&D Leaders
BenchSci has welcomed three new members to its advisory board from the pharmacology sector. Steve Hitchcock of Takeda…
EF Hutton Initiates Coverage of Cel-Sci (CVM) with $17 Price Target Ahead of Rumored News
Tim Moore, CFA an Analyst at EF Hutton has recently published a report citing the opportunities for growth…
Legend Biotech Appoints Dr. Guowei Fang As Head of Global Research and Early Development
Global biotechnology company Legend Biotech Corporation (NASDAQ: LEGN) announced today that Guowei Fang, Ph.D. will take over as…
2seventy bio Secure $170 Million Extending Cash Runway Into 2025
2seventy bio (Nasdaq: TSVT), a leading immuno-oncology cell therapy company, today announced that it has agreed to sell…
Inhibikase Therapeutics To Present Phase 1/1b Trial Results at AD/PD Alzheimer’s & Parkinson’s Diseases Conference
Clinical-stage pharmaceutical company Inhibikase Therapeutics, Inc. (Nasdaq: IKT) recently announced that President and CEO Dr. Milton Werner, Ph.D. will be…
Celyad Oncology Pauses CYAD-101-002 (Keynote-B79) Phase 1 Trial After 2 Deaths Reported
Clinical-stage biotechnology company Celyad Oncology (NASDAQ: CYAD) recently announced that the company has voluntarily paused the CYAD-101-002 (KEYNOTE-B79)…
Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
With the appointments of these experts, the firm has added to its industry knowledge, including Chief Scientific Officer…